Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New exportin-1 inhibitors show preclinical potential in MCL and MM

Dec. 28, 2011

CytRx launches phase IIb study in advanced soft tissue sarcoma

Dec. 27, 2011

First patient with metastasized colorectal cancer treated in phase II trial of armed oncolytic virus

Dec. 27, 2011

Exelixis grants program license to Merck & Co.

Dec. 27, 2011

Novel farnesyl pyrophosphate synthase inhibitors discovered in Canada

Dec. 27, 2011

Merck & Co. patents new hPDK1 inhibitors

Dec. 27, 2011

Oral rigosertib shows promise as a therapy for myelodysplastic syndrome

Dec. 27, 2011

Phase I study evaluates SCH-900776/cytarabine combination for leukemia

Dec. 27, 2011

Phase II ARRY-520 trial in multiple myeloma yields encouraging results

Dec. 27, 2011

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Dec. 23, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026